Go Quick Evogene 12mg Injection

Go Quick Evogene 12mg Injection

Evogene 12mg Injection is a pharmaceutical product used for the treatment of certain medical conditions, primarily related to oncology (cancer treatment) or autoimmune diseases. It typically contains the active ingredient Eculizumab (marketed under the brand name Soliris in some regions), which is a monoclonal antibody.

Key Details about Evogene 12mg Injection:

• Active Ingredient: Eculizumab.
• Brand Name: Evogene (this may vary depending on the country or manufacturer).
• Strength: 12 mg.
• Form: Injection (intravenous use).
• Indications: It is commonly used for the treatment of diseases involving the complement system, such as:
  • Paroxysmal nocturnal hemoglobinuria (PNH): A rare, life-threatening disease that causes red blood cell destruction.
  • Atypical hemolytic uremic syndrome (aHUS): A rare condition that leads to the destruction of red blood cells, kidney failure, and thrombosis (blood clots).
  • Neuromyelitis optica spectrum disorder (NMOSD): A condition that affects the optic nerves and spinal cord.
  • Other complement-mediated disorders.

Mechanism of Action:

Eculizumab works by inhibiting complement component 5 (C5), which is part of the immune system’s complement pathway. By inhibiting this component, the drug helps to prevent the damage caused by overactivation of the complement system, which can occur in various autoimmune and rare genetic disorders.Go Quick Evogene 12mg Injection

Dosage and Administration:

• Evogene (Eculizumab) is typically administered intravenously under the supervision of a healthcare professional.
• The dosage and frequency depend on the specific condition being treated and the patient’s response to therapy.

Common Side Effects:

Some common side effects associated with Evogene 12mg Injection or similar treatments include:

• Headache
• Nausea
• Fever
• Fatigue
• Increased risk of infections, particularly Neisseria meningitidis (a type of bacteria that causes meningitis), so patients are usually vaccinated before starting therapy.

Precautions:

• Vaccination: Patients should be vaccinated against meningococcal infections, as eculizumab increases the risk of serious infections like meningitis.
• Infection Risk: Close monitoring for infections is necessary, and patients may need prophylactic antibiotics.
• Allergic reactions: Rarely, patients may experience allergic reactions during or after the infusion.

Conclusion:

Evogene 12mg Injection is a highly specialized medication with a focus on conditions driven by immune system dysfunction. As it involves significant risks like infection, it must be managed under close medical supervision, with appropriate precautions like vaccination and monitoring.

Please consult your healthcare provider for further information, as this summary may not capture all the details specific to your situation.